These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 24512088)

  • 1. Medication utilization and adherence in a health savings account-eligible plan.
    Fronstin P; Sepulveda MJ; Roebuck MC
    Am J Manag Care; 2013 Dec; 19(12):e400-7. PubMed ID: 24512088
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the effect of a consumer-driven health plan on medical care expenditures and utilization.
    Parente ST; Feldman R; Christianson JB
    Health Serv Res; 2004 Aug; 39(4 Pt 2):1189-210. PubMed ID: 15230920
    [TBL] [Abstract][Full Text] [Related]  

  • 3. What do we really know about consumer-driven health plans?
    Fronstin P
    EBRI Issue Brief; 2010 Aug; (345):1-27. PubMed ID: 20929166
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Findings from the 2012 EBRI/MGA Consumer Engagement in Health Care Survey.
    Fronstin P
    EBRI Issue Brief; 2012 Dec; (379):1-27. PubMed ID: 23390734
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Findings from the 2009 EBRI/MGA Consumer Engagement in Health Care Survey.
    Fronstin P
    EBRI Issue Brief; 2009 Dec; (337):1-42. PubMed ID: 20043408
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Findings from the 2011 EBRI/MGA Consumer Engagement in Health Care Survey.
    Fronstin P
    EBRI Issue Brief; 2011 Dec; (365):1-26. PubMed ID: 22312794
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Consumer experiences in a consumer-driven health plan.
    Christianson JB; Parente ST; Feldman R
    Health Serv Res; 2004 Aug; 39(4 Pt 2):1123-40. PubMed ID: 15230916
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of chronic obstructive pulmonary disease maintenance medication adherence with all-cause hospitalization and spending in a Medicare population.
    Simoni-Wastila L; Wei YJ; Qian J; Zuckerman IH; Stuart B; Shaffer T; Dalal AA; Bryant-Comstock L
    Am J Geriatr Pharmacother; 2012 Jun; 10(3):201-10. PubMed ID: 22521808
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Do medical homes increase medication adherence for persons with multiple chronic conditions?
    Beadles CA; Farley JF; Ellis AR; Lichstein JC; Morrissey JP; DuBard CA; Domino ME
    Med Care; 2015 Feb; 53(2):168-76. PubMed ID: 25517069
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Consumer-driven health plans: impact on utilization and expenditures for chronic disease sufferers.
    Nair KV; Park J; Wolfe P; Saseen JJ; Allen RR; Ganguly R
    J Occup Environ Med; 2009 May; 51(5):594-603. PubMed ID: 19369897
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of a consumer driven health plan on pharmaceutical spending and utilization.
    Parente ST; Feldman R; Chen S
    Health Serv Res; 2008 Oct; 43(5 Pt 1):1542-56. PubMed ID: 18479407
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The implications of choice: prescribing generic or preferred pharmaceuticals improves medication adherence for chronic conditions.
    Shrank WH; Hoang T; Ettner SL; Glassman PA; Nair K; DeLapp D; Dirstine J; Avorn J; Asch SM
    Arch Intern Med; 2006 Feb; 166(3):332-7. PubMed ID: 16476874
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of a patient-centered pharmacy program and intervention in a high-risk group.
    Moore JM; Shartle D; Faudskar L; Matlin OS; Brennan TA
    J Manag Care Pharm; 2013 Apr; 19(3):228-36. PubMed ID: 23537457
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of increased adherence and cost savings of an employer value-based benefits program targeting generic antihyperlipidemic and antidiabetic medications.
    Clark B; DuChane J; Hou J; Rubinstein E; McMurray J; Duncan I
    J Manag Care Pharm; 2014 Feb; 20(2):141-50. PubMed ID: 24456315
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Employee choice of consumer-driven health insurance in a multiplan, multiproduct setting.
    Parente ST; Feldman R; Christianson JB
    Health Serv Res; 2004 Aug; 39(4 Pt 2):1091-112. PubMed ID: 15230913
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early experience with employee choice of consumer-directed health plans and satisfaction with enrollment.
    Fowles JB; Kind EA; Braun BL; Bertko J
    Health Serv Res; 2004 Aug; 39(4 Pt 2):1141-58. PubMed ID: 15230917
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validity of the adherence estimator in the prediction of 9-month persistence with medications prescribed for chronic diseases: a prospective analysis of data from pharmacy claims.
    McHorney CA; Victor Spain C; Alexander CM; Simmons J
    Clin Ther; 2009 Nov; 31(11):2584-607. PubMed ID: 20110004
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adherence to Metformin, Statins, and ACE/ARBs Within the Diabetes Health Plan (DHP).
    Duru OK; Turk N; Ettner SL; Neugebauer R; Moin T; Li J; Kimbro L; Chan C; Luchs RH; Keckhafer AM; Kirvan A; Ho S; Mangione CM
    J Gen Intern Med; 2015 Nov; 30(11):1645-50. PubMed ID: 25944019
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of health savings account-eligible plans on utilization and expenditures.
    Charlton ME; Levy BT; High RR; Schneider JE; Brooks JM
    Am J Manag Care; 2011 Jan; 17(1):79-86. PubMed ID: 21348571
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of drug plans on adherence to and the cost of antihypertensive medications among patients covered by a universal drug insurance program.
    Després F; Perreault S; Lalonde L; Forget A; Kettani FZ; Blais L
    Can J Cardiol; 2014 May; 30(5):560-7. PubMed ID: 24613090
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.